Stacie Dodgson, PhD
@staciedodgson.bsky.social
Chief Scientific Strategist, Gladstone-UCSF Institute of Genomic Immunology.
Former Cell editor.
Genetics, genomics, immunology, oceanology, mixology, always collecting new -ologies.
Former Cell editor.
Genetics, genomics, immunology, oceanology, mixology, always collecting new -ologies.
Reposted by Stacie Dodgson, PhD
A very simple script. Feel free to adjust for your needs.
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
February 8, 2025 at 2:02 PM
A very simple script. Feel free to adjust for your needs.
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
"I JUST READ THAT MUSK AND TRUMP ARE CUTTING BILLIONS OF DOLLARS IN CANCER AND ALZHEIMER RESEARCH MONEY. I DIDN'T VOTE FOR CANCER. ARE YOU SUPPORTING THIS? WHAT ARE YOU DOING TO STOP THEM?"
reps.fyi
Reposted by Stacie Dodgson, PhD
For me it is "Naturally occurring T cell mutations enhance engineered T cell therapies"
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
Naturally occurring T cell mutations enhance engineered T cell therapies - Nature
A study examines the effects of mutations that occur naturally in T cell cancers, reporting that such mutations can potentially be exploited to increase the potency of T cell therapies.
www.nature.com
December 27, 2024 at 3:21 PM
For me it is "Naturally occurring T cell mutations enhance engineered T cell therapies"
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.
The idea is so simple: use naturally occurring somatic mutations as an in vivo screen. Evolution finds mutations that improve T-cell persistence and survival which would not have been discovered with CRISPR.